Southern Acids (malaysia) Bhd. · MYX:SAB
Southern Acids (malaysia) Bhd — Southern Acids (M) Berhad — Shareholder Meeting (August 2015)
16 slides from Southern Acids (malaysia) Bhd's shareholder meeting presentation, Aug 28, 2015
Slide 1: Southern Acids (M) Berhad 34th Annual General Meeting
SOUTHERN ACIDS (M) BERHAD 34TH ANNUAL GENERAL MEETING 28 AUGUST 2015
Slide 2: Shareholders' Briefing Information
Shareholders’ Briefing Information This briefing is mainly on the summary of the key highlights of the Chairman’s Statement and Management Discussion And Analysis (“MDA”) as stated in the Company’s 2015 Annual Report (“2015 AR”). Information contained in this briefing is solely based on 2015 AR and
Slide 3: Presentation Contents
Presentation Contents 1. Southern Acids (M) Berhad (“SAB”) & Its Subsidiaries (“Southern Acids”) Financial Highlights 2. Review Of Business Divisions 3. Prospects 4. Questions & Answers
Slide 4: Southern Acids FY2015
Hl SOUTHERN Ms oat, ACIDS z FY2015
Slide 5: Selected Financial Highlights for FY2015 and FY2014
SELECTED FINANCIAL HIGHTLIGHTS FOR FY2015 And FY2014 FY2015 (RM’000) FY2014 (RM’000) Change Revenue 562,029 544,055 3.3% 43,691 65,577 33.4% Profit before tax Profit for the year 34,106 48,178 29.3% Profit Attributable to equity holders of the 27,521 38,418 28.4% Company Earnings per share 20.1 sen
Slide 6: Selected Financial Highlights for FY2015 and FY2014
SELECTED FINANCIAL HIGHLIGHTS FOR FY2015 And FY2014 FY2015 (RM’000) FY2014 (RM’000) Change Total Assets 604,922 583,635 3.6% Total Liabilities 65,847 68,472 3.9% Net Current Assets 211,364 217,322 2.7% Equity Attributable to Shareholders of the 493,392 474,571 4.0% Company
Slide 7: Group's Revenue and Profit Before Tax
Group’s Revenue And Profit Before Tax (“PBT”) FY2015 FY2014 Variance Variance RM’000 RM’000 RM’000 % Revenue 562,029 544,055 17,974 3.3 PBT 43,691 65,577 (21,886) 33.4 Highlights:- • 3.3% increase in revenue compared to FYE 31 March 2014 (“FY2014”); and • 33.4% decrease in PBT compared to FY2014 The
Slide 8: Southern Acids FY2015
SOUTHERN ACIDS FY2015
Slide 9: Review of Oleochemical Business Division
Review of Oleochemical Business Divisions FY2015 FY2014 Variance Variance RM’000 RM’000 RM’000 % Revenue 349,850 341,788 8,062 2.4 PBT 9,038 27,869 (18,831) (67.6) Highlights:- • 2.4% increase in revenue which was due to 6.1% higher in average selling price (“ASP”) of fatty acids however sales volum
Slide 10: Prospects of Oleochemical Division
Prospects Of Oleochemical Division Highlights:- • The plant production is expected to run at near full capacity however its performance is subject to the following:- – Slowdown in global economy, more so currently; – rising operating costs such as utilities, labor and compliance; – keen competition
Slide 11: Review of Plantation & Milling Division
Review of Plantation & Milling Division FY2015 FY2014 Variance Variance RM’000 RM’000 RM’000 % Revenue 106,041 113,917 (7,876) (6.9) PBT 23,660 34,422 (10,762) (31.3) Highlights:- • 6.9% lower in revenue was mainly due to 6.3% reduction in sales volume and 2.3% lower in ASP;. • The RM10.8m lower in
Slide 12: Prospects of Plantation & Milling Division
Prospects Of Plantation & Milling Division Highlights :- The performance of this Division is subject to the following:- – CPO prices; – Weather condition; – Changes in Indonesian regulations (such as minimum wages & ISPO); and – MYR/IDR exchange rate. • Further reduction in the total planted and mat
Slide 13: Review of Healthcare Division
Review of Healthcare Division FY2015 FY2014 Variance Variance RM’000 RM’000 RM’000 % Revenue 92,125 76,421 15,704 20.5 PBT 9,306 3,477 5,829 167.6 Highlights:- • 20.5% and 167.6% increase in revenue and PBT respectively which were due to higher inpatient income from the epidemic outbreak.
Slide 14: Prospects of Healthcare Division
Prospects Of Healthcare Division Highlights :- • The revenue and PBT may be lowered especially if the epidemic outbreak is contained; • The Division is working to bring in more full time consultants to build on its existing core disciplines and the possibility of introducing new disciplines to broad
Slide 15: Prospects of Southern Acids
Prospects Of Southern Acids Based on the earlier prospects commentary, the performance of Southern Acids will remain challenging and as such will continue to take necessary steps to maintain good financial performance for the current FY2016
Slide 16: Thank You!
Thank You !
Southern Acids (M) Berhad — Shareholder Meeting (August 2015) on 6ix